Segall Bryant & Hamill LLC Acquires Shares of 56,161 ZimVie Inc. (NASDAQ:ZIMV)

Segall Bryant & Hamill LLC acquired a new stake in ZimVie Inc. (NASDAQ:ZIMV) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 56,161 shares of the company’s stock, valued at approximately $891,000. Segall Bryant & Hamill LLC owned 0.20% of ZimVie at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Gabelli Funds LLC grew its stake in shares of ZimVie by 2.0% during the 1st quarter. Gabelli Funds LLC now owns 41,060 shares of the company’s stock worth $677,000 after acquiring an additional 800 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of ZimVie by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock worth $356,000 after acquiring an additional 1,275 shares during the period. Kennedy Capital Management LLC grew its stake in shares of ZimVie by 8.8% during the 1st quarter. Kennedy Capital Management LLC now owns 240,686 shares of the company’s stock worth $3,969,000 after acquiring an additional 19,386 shares during the period. EMC Capital Management bought a new position in shares of ZimVie during the 1st quarter worth $228,000. Finally, Cetera Advisors LLC bought a new position in shares of ZimVie during the 1st quarter worth $2,615,000. Institutional investors own 95.63% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC increased their price target on ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd.

ZimVie Stock Performance

Shares of ZIMV opened at $14.17 on Monday. The stock’s 50-day simple moving average is $14.88 and its 200 day simple moving average is $16.64. ZimVie Inc. has a 52-week low of $9.00 and a 52-week high of $22.40. The stock has a market capitalization of $391.08 million, a price-to-earnings ratio of -1.08 and a beta of 2.14. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.